These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 28709489

  • 1. The success and safety profile of sputum induction in patients with chronic obstructive pulmonary disease: An Indian experience.
    Fernandes L, Mesquita AM.
    Indian J Tuberc; 2017 Jul; 64(3):201-205. PubMed ID: 28709489
    [Abstract] [Full Text] [Related]

  • 2. Post-bronchodilator Reversibility of FEV1 and Eosinophilic Airway Inflammation in COPD.
    Chou KT, Su KC, Hsiao YH, Huang SF, Ko HK, Tseng CM, Su VY, Perng DW.
    Arch Bronconeumol; 2017 Oct; 53(10):547-553. PubMed ID: 28438346
    [Abstract] [Full Text] [Related]

  • 3. Safety of sputum induction during exacerbations of COPD.
    Bathoorn E, Liesker J, Postma D, Koëter G, van Oosterhout AJ, Kerstjens HA.
    Chest; 2007 Feb; 131(2):432-8. PubMed ID: 17296644
    [Abstract] [Full Text] [Related]

  • 4. The safety of sputum induction in adults with acute exacerbation of COPD.
    Gao P, Gibson PG, Zhang J, He X, Hao Y, Li P, Liu H.
    Clin Respir J; 2013 Jan; 7(1):101-9. PubMed ID: 22452898
    [Abstract] [Full Text] [Related]

  • 5. Safety of sputum induction in moderate-to-severe smoking-related chronic obstructive pulmonary disease.
    Wilson AM, Leigh R, Hargreave FE, Pizzichini MM, Pizzichini E.
    COPD; 2006 Jun; 3(2):89-93. PubMed ID: 17175671
    [Abstract] [Full Text] [Related]

  • 6. Safety of sputum induction in chronic obstructive pulmonary disease.
    Rytilä PH, Lindqvist AE, Laitinen LA.
    Eur Respir J; 2000 Jun; 15(6):1116-9. PubMed ID: 10885433
    [Abstract] [Full Text] [Related]

  • 7. Characteristics of airway inflammation and bronchodilator reversibility in COPD: a potential guide to treatment.
    Perng DW, Huang HY, Chen HM, Lee YC, Perng RP.
    Chest; 2004 Aug; 126(2):375-81. PubMed ID: 15302720
    [Abstract] [Full Text] [Related]

  • 8. Safety of sputum induction in moderate-to-severe chronic obstructive pulmonary disease.
    Sutherland ER, Pak J, Langmack EL, Silkoff PE, Martin RJ.
    Respir Med; 2002 Jul; 96(7):482-6. PubMed ID: 12194630
    [Abstract] [Full Text] [Related]

  • 9. Success and safety of sputum induction in the clinical setting.
    Vlachos-Mayer H, Leigh R, Sharon RF, Hussack P, Hargreave FE.
    Eur Respir J; 2000 Nov; 16(5):997-1000. PubMed ID: 11153606
    [Abstract] [Full Text] [Related]

  • 10. [Induced sputum in children and adolescents with asthma: safety, clinical applicability and inflammatory cells aspects in stable patients and during exacerbation].
    Palomino AL, Bussamra MH, Saraiva-Romanholo BM, Martins MA, Nunes Mdo P, Rodrigues JC.
    J Pediatr (Rio J); 2005 Nov; 81(3):216-24. PubMed ID: 15951906
    [Abstract] [Full Text] [Related]

  • 11. Airway response to inhaled hypertonic saline in patients with moderate to severe chronic obstructive pulmonary disease.
    Taube C, Holz O, Mücke M, Jörres RA, Magnussen H.
    Am J Respir Crit Care Med; 2001 Nov 15; 164(10 Pt 1):1810-5. PubMed ID: 11734428
    [Abstract] [Full Text] [Related]

  • 12. Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability.
    Brightling CE, Monterio W, Green RH, Parker D, Morgan MD, Wardlaw AJ, Pavord D.
    Respir Med; 2001 Dec 15; 95(12):999-1002. PubMed ID: 11778799
    [Abstract] [Full Text] [Related]

  • 13. Role of sputum differential cell count in detecting airway inflammation in patients with chronic bronchial asthma or COPD.
    Ronchi MC, Piragino C, Rosi E, Amendola M, Duranti R, Scano G.
    Thorax; 1996 Oct 15; 51(10):1000-4. PubMed ID: 8977600
    [Abstract] [Full Text] [Related]

  • 14. Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.
    Müller V, Gálffy G, Orosz M, Kováts Z, Odler B, Selroos O, Tamási L.
    Int J Chron Obstruct Pulmon Dis; 2016 Oct 15; 11():93-101. PubMed ID: 26834466
    [Abstract] [Full Text] [Related]

  • 15. Albuterol inhalation increases FeNO level in steroid-naive asthmatics but not COPD patients with reversibility.
    Zhao H, Li R, Lv Y, Dong H, Yao L, Wu Y, Xiao G, Cai S.
    Clin Respir J; 2017 May 15; 11(3):328-336. PubMed ID: 26077165
    [Abstract] [Full Text] [Related]

  • 16. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
    Xin XF, Zhao M, Li ZL, Song Y, Shi Y.
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar 15; 30(3):192-6. PubMed ID: 17572998
    [Abstract] [Full Text] [Related]

  • 17. Changes in sputum composition during 15 min of sputum induction in healthy subjects and patients with asthma and chronic obstructive pulmonary disease.
    Toungoussova O, Migliori GB, Foschino Barbaro MP, Esposito LM, Dragonieri S, Carpagnano GE, Salerno FG, Neri M, Spanevello A.
    Respir Med; 2007 Jul 15; 101(7):1543-8. PubMed ID: 17258444
    [Abstract] [Full Text] [Related]

  • 18. Sputum induction in corticosteroid-dependant asthmatics: risks and airway cellular profile.
    Loh LC, Kanabar V, D'Amato M, Barnes NC, O'Connor BJ.
    Asian Pac J Allergy Immunol; 2005 Dec 15; 23(4):189-96. PubMed ID: 16572738
    [Abstract] [Full Text] [Related]

  • 19. Dyspnea assessment and adverse events during sputum induction in COPD.
    Makris D, Tzanakis N, Moschandreas J, Siafakas NM.
    BMC Pulm Med; 2006 Jun 29; 6():17. PubMed ID: 16808839
    [Abstract] [Full Text] [Related]

  • 20. The safety and success rate of sputum induction using a low output ultrasonic nebuliser.
    Hunter CJ, Ward R, Woltmann G, Wardlaw AJ, Pavord ID.
    Respir Med; 1999 May 29; 93(5):345-8. PubMed ID: 10464902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.